Award recordCONTRACT

UNITED THERAPEUTICS CORP

PIID VA26215J0610· VHA· 262-NETWORK CONTRACT OFFICE 22· 6505 · DRUGS AND BIOLOGICALS· FY2015· $323,424 net obligations· UEI KK5FBFA43JS7· MD

Description

TYVASSO REFILL KIT

Base award description: PHARMACEUTICAL DRUGS: TYVASSO REFILL KIT

First action · last action
2014-10-21 · 2016-02-02
Transactions
3
First transaction's obligation
$96,370
Base + all options value (sum of deltas)
$323,424
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
Parent IDV
VA797BP0424
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 3 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$326,371$0Base award · 2014-10-21 · this action $96,370 · running total $96,370Modification P00001 · 2015-06-12 · this action $230,001 · running total $326,371Modification P00002 · 2016-02-02 · this action -$2,947 · running total $323,424
  • Base2014-10-21+$96,370= $96,370
  • Mod P000012015-06-12+$230,001= $326,371
  • Mod P000022016-02-02-$2,947= $323,424
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2014-10-21+$96,370$96,370PHARMACEUTICAL DRUGS: TYVASSO REFILL KIT
Mod P00001· FUNDING ONLY ACTION2015-06-12+$230,001$326,371PHARMACEUTICAL DRUGS: TYVASSO REFILL KIT
Mod P00002· FUNDING ONLY ACTION2016-02-02−$2,947$323,424TYVASSO REFILL KIT

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI KK5FBFA43JS7)

AwardOffice · PSC / listingNet obligationsFY
36C24526N0777245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$33,158FY2026
36C24526N0755245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$17,352FY2026
36C24526N0754245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$15,746FY2026
36C24526N0723245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$17,352FY2026
36C24526N0722245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$17,352FY2026
36C24526N0707245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$17,352FY2026

Other recipients under 6505 from 262-NETWORK CONTRACT OFFICE 22 (most recent first)

AwardRecipientOfficeNet obligationsFY
VA26216J3405SANOFI VACCINES US INC.262-NETWORK CONTRACT OFFICE 22$209,679FY2016
VA26216P3483JOHNSON & JOHNSON HEALTH CARE SYSTEMS INC.262-NETWORK CONTRACT OFFICE 22$14,960FY2016
VA26216E3967MCKESSON CORPORATION262-NETWORK CONTRACT OFFICE 22$20,913,958FY2016
VA26216P2987PETNET SOLUTIONS, INC.262-NETWORK CONTRACT OFFICE 22$58,136FY2016
VA26216E3446MCKESSON CORPORATION262-NETWORK CONTRACT OFFICE 22$11,612,703FY2016

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA26215J0610_3600_VA797BP0424_3600 · retrieved 2026-09-26.